[go: up one dir, main page]

ZA94711B - Heterocyclic compounds and their preparation and use - Google Patents

Heterocyclic compounds and their preparation and use

Info

Publication number
ZA94711B
ZA94711B ZA94711A ZA94711A ZA94711B ZA 94711 B ZA94711 B ZA 94711B ZA 94711 A ZA94711 A ZA 94711A ZA 94711 A ZA94711 A ZA 94711A ZA 94711 B ZA94711 B ZA 94711B
Authority
ZA
South Africa
Prior art keywords
preparation
heterocyclic compounds
indeno
diones
pyrazin
Prior art date
Application number
ZA94711A
Other languages
English (en)
Inventor
Peter Faarup
Palle Jakobsen
Anker Steen Jorgensen
Hendrik Klitgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA94711B publication Critical patent/ZA94711B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Liquid Crystal Substances (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
ZA94711A 1993-02-02 1994-02-02 Heterocyclic compounds and their preparation and use ZA94711B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93122A DK12293D0 (da) 1993-02-02 1993-02-02 Heterocykliske forbindelser og deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
ZA94711B true ZA94711B (en) 1995-08-02

Family

ID=8090000

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94711A ZA94711B (en) 1993-02-02 1994-02-02 Heterocyclic compounds and their preparation and use

Country Status (14)

Country Link
US (2) US5468748A (fi)
EP (1) EP0682657B1 (fi)
JP (1) JPH08508979A (fi)
AT (1) ATE160342T1 (fi)
AU (1) AU674205B2 (fi)
CA (1) CA2155355A1 (fi)
DE (1) DE69406907D1 (fi)
DK (1) DK12293D0 (fi)
FI (1) FI953666L (fi)
IL (1) IL108486A (fi)
NO (1) NO953034L (fi)
NZ (1) NZ261299A (fi)
WO (1) WO1994018175A1 (fi)
ZA (1) ZA94711B (fi)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717813B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant .
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6270464B1 (en) * 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6638234B2 (en) 1998-03-03 2003-10-28 Senorx, Inc. Sentinel node location and biopsy
US6497706B1 (en) 1998-03-03 2002-12-24 Senorx, Inc. Biopsy device and method of use
US6875182B2 (en) * 1998-03-03 2005-04-05 Senorx, Inc. Electrosurgical specimen-collection system
US6758848B2 (en) 1998-03-03 2004-07-06 Senorx, Inc. Apparatus and method for accessing a body site
US6540695B1 (en) 1998-04-08 2003-04-01 Senorx, Inc. Biopsy anchor device with cutter
US6161034A (en) * 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6347241B2 (en) * 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US20020058882A1 (en) * 1998-06-22 2002-05-16 Artemis Medical, Incorporated Biopsy localization method and device
US6679851B2 (en) * 1998-09-01 2004-01-20 Senorx, Inc. Tissue accessing and anchoring device and method
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US20090030309A1 (en) * 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
CA2446993C (en) 2000-11-20 2009-06-02 Senorx, Inc. Tissue site markers for in vivo imaging
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7125586B2 (en) * 2003-04-11 2006-10-24 Delphi Technologies, Inc. Kinetic spray application of coatings onto covered materials
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US9408592B2 (en) 2003-12-23 2016-08-09 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US8360990B2 (en) 2004-12-16 2013-01-29 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US8820447B2 (en) * 2005-03-18 2014-09-02 Gatekeeper Systems, Inc. Power generation systems and methods for wheeled objects
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US9095325B2 (en) 2005-05-23 2015-08-04 Senorx, Inc. Tissue cutting member for a biopsy device
US7572236B2 (en) 2005-08-05 2009-08-11 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8317725B2 (en) 2005-08-05 2012-11-27 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
CA2562580C (en) 2005-10-07 2014-04-29 Inrad, Inc. Drug-eluting tissue marker
US20080230001A1 (en) * 2006-02-23 2008-09-25 Meadwestvaco Corporation Method for treating a substrate
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
EP2109409B1 (en) 2006-12-12 2018-09-05 C.R.Bard, Inc. Multiple imaging mode tissue marker
WO2008076973A2 (en) 2006-12-18 2008-06-26 C.R.Bard Inc. Biopsy marker with in situ-generated imaging properties
PT2221296E (pt) * 2007-11-28 2012-11-23 Astellas Pharma Inc Composto de indano fundido
WO2009099767A2 (en) 2008-01-31 2009-08-13 C.R. Bard, Inc. Biopsy tissue marker
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
JP5453453B2 (ja) 2008-12-30 2014-03-26 シー・アール・バード・インコーポレーテッド 組織マーカの配置のためのマーカ伝送装置
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .

Also Published As

Publication number Publication date
US5468748A (en) 1995-11-21
FI953666A0 (fi) 1995-08-01
ATE160342T1 (de) 1997-12-15
NO953034L (no) 1995-09-29
DE69406907D1 (de) 1998-01-02
IL108486A (en) 1998-01-04
EP0682657B1 (en) 1997-11-19
IL108486A0 (en) 1994-05-30
CA2155355A1 (en) 1994-08-18
DK12293D0 (da) 1993-02-02
US5646146A (en) 1997-07-08
AU5998694A (en) 1994-08-29
NZ261299A (en) 1997-02-24
AU674205B2 (en) 1996-12-12
WO1994018175A1 (en) 1994-08-18
FI953666L (fi) 1995-09-28
EP0682657A1 (en) 1995-11-22
JPH08508979A (ja) 1996-09-24
NO953034D0 (no) 1995-08-01

Similar Documents

Publication Publication Date Title
ZA94711B (en) Heterocyclic compounds and their preparation and use
WO1997035539A3 (en) Arylamino fused pyridines and pyrimidines
HU0103927D0 (en) Intermediates of pyrrolo[2,3-d]pyrimidine derivatives and process for the preparation thereof
CA2118704A1 (en) Fused Tricyclic Nitrogen Containing Heterocycles as Substance P Receptor Antagonists
NZ329627A (en) 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones
AU9693998A (en) Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
HU9402653D0 (en) Optionally substituted pyrido[5,3-d]-pyrimidine-2,4-(1h,3h)-diones and pyrido[2,3-d]pyrimidine-2-(1h,3h)-ones
MX9702307A (es) Pirrolo (2,3-d)pirimidinas y su uso.
BG102478A (en) N-([1,2,4]triazolazinyl)benzenesulphonamide and pyridinesulphanamide compunds and their application as herbicides
BG103417A (en) Condensed pyrimidine bicyclic derivatives
ZA973884B (en) Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
DE69007891D1 (de) 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one und -thione und ihre Verwendung bei der AIDS-Vorbeugung oder -Behandlung.
HU9203325D0 (en) Benzo-thieno(2,3-b)pyrazine-2,3(1h,4h)-dione derivatives
AU4698199A (en) Pyrazolo(1,5-a)triazine corticotropin releasing factor antagonists
ZA928096B (en) Heterocyclic compounds and their preparation and use
GR852525B (fi)
ATE116320T1 (de) 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.
TW239116B (fi)
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
ATE209036T1 (de) Verwendung von imidazo(a,5-a)quinolonen als neuroprotektive arzneimittel
DE59809929D1 (de) 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1,2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo[3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten
MX9700716A (es) 2-aril-5,11-dihidro-6h-dipirido[3,2-b:2',3'-e][1,4] diazepinas y su uso en el tratamiento de la infeccion por vih.